Table 2 OCT measurements during the study period
From: OCT macular changes in type 1 ROP following Ranibizumab injections
Baseline (n = 22) | One week (n = 22) | One Month (n = 18) | p value | |
|---|---|---|---|---|
Central foveal thickness µm ± SD (range) | `250.8 ± 104.3 (112—461) | 268.1 ± 147.1 (115—571) | 252.1 ± 132.2 (128—520) | 0.54 |
Outer retinal layers thickness µm ± SD (range) | 69.95 ± 16.47 (48–104) | 79.41 ± 22.11 (48—128) | 96.17 ± 25.34 (55—133) | 0.0006 |
Inner retinal layer thickness µm ± SD (Range) | 180.9 ± 103 (52—388) | 188.7 ± 147.8 (21—483) | 155.9 ± 146.2 (17- 42) | 0.17 |
Fovea-parafoveal ratio | 0.85 ± 0.25 (0.46–1.28) | 0.84 ± 0.32 (0.4–1.49) | 0.79 ± 0.29 (0.46–1.29) | 0.2 |